{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:35:45Z","timestamp":1782358545193,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017332","name":"Rafsanjan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["97000103"],"award-info":[{"award-number":["97000103"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["97456"],"award-info":[{"award-number":["97456"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cyto.2024.156721","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T08:28:38Z","timestamp":1722846518000},"page":"156721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of the CCL17\/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course"],"prefix":"10.1016","volume":"182","author":[{"given":"Marzieh","family":"Motaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Farsinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farahmandinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Afgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamhossein","family":"Hassanshahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156721_b0005","doi-asserted-by":"crossref","unstructured":"Sousa, D.W.L.d., et al., Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Revista brasileira de hematologia e hemoterapia, 2015. 37: p. 223-229.","DOI":"10.1016\/j.bjhh.2015.03.009"},{"issue":"6","key":"10.1016\/j.cyto.2024.156721_b0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjh.14474","article-title":"Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics","volume":"176","author":"Tasian","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"14","key":"10.1016\/j.cyto.2024.156721_b0015","first-page":"2807","article-title":"How I treat relapsed childhood acute lymphoblastic leukemia","volume":"120","author":"Locatelli","year":"2012","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"10.1016\/j.cyto.2024.156721_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01060-y","article-title":"Targeting chemokines for acute lymphoblastic leukemia therapy","volume":"14","author":"Hong","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156721_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2006-7-12-243","article-title":"The chemokine and chemokine receptor superfamilies and their molecular evolution","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156721_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156721_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","article-title":"Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine","volume":"11","author":"Imai","year":"1999","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156721_b0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.yexcr.2011.01.005","article-title":"Chemokines in health and disease","volume":"317","author":"Raman","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cyto.2024.156721_b0045","unstructured":"Cignetti, A., et al. Chemokine receptor expression in acute myeloid leukemia cells. in BLOOD. 2000. AMER SOC Hematology 1900 M Street. NW Suite 200, Washington, DC 20036 USA."},{"key":"10.1016\/j.cyto.2024.156721_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2015.00012","article-title":"Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges","volume":"6","author":"Vela","year":"2015","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156721_b0055","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24794","article-title":"Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies","volume":"92","author":"Perera","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156721_b0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1349-7006.2010.01767.x","article-title":"Immunopathogenesis of lymphoma: focus on CCR4","volume":"102","author":"Ishida","year":"2011","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.cyto.2024.156721_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2040620716636541","article-title":"Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential","volume":"7","author":"Duvic","year":"2016","journal-title":"Therapeutic Advances in Hematology"},{"issue":"1","key":"10.1016\/j.cyto.2024.156721_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1600-0609.2011.01613.x","article-title":"CCR4 expression in a case of cutaneous Richter\u2019s transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations","volume":"87","author":"Nannini","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156721_b0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00262-015-1675-7","article-title":"CCL17 and CCL22\/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer\/T-cell lymphoma","volume":"64","author":"Kumai","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.cyto.2024.156721_b0080","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/sj.leu.2404415","article-title":"The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma","volume":"20","author":"Ishida","year":"2006","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.cyto.2024.156721_b0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1349-7006.2006.00307.x","article-title":"CCR4 as a novel molecular target for immunotherapy of cancer","volume":"97","author":"Ishida","year":"2006","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.cyto.2024.156721_b0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1189\/jlb.1105633","article-title":"Chemokines, chemokine receptors, and cancer metastasis","volume":"79","author":"Kakinuma","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156721_b0095","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.molonc.2015.04.004","article-title":"Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4+ cells in vivo","volume":"9","author":"Wang","year":"2015","journal-title":"Mol. Oncol."},{"issue":"22","key":"10.1016\/j.cyto.2024.156721_b0100","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-04-0983","article-title":"The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia\/lymphoma","volume":"10","author":"Ishida","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.cyto.2024.156721_b0105","doi-asserted-by":"crossref","first-page":"e19627","DOI":"10.1097\/MD.0000000000019627","article-title":"Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations","volume":"99","author":"Merdin","year":"2020","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.cyto.2024.156721_b0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood.V56.3.351.351","article-title":"Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia","volume":"56","author":"Kornberg","year":"1980","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.cyto.2024.156721_b0115","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.3390\/ijms232415638","article-title":"CC chemokine receptor 4 (CCR4) as a possible new target for therapy","volume":"23","author":"Bogacka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2024.156721_b0120","first-page":"169","article-title":"Serum lactate dehydrogenase as a prognostic marker of childhood acute lymphoblastic leukemia","volume":"17","author":"Hafiz","year":"2008","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.cyto.2024.156721_b0125","first-page":"1","article-title":"Lactate Dehydrogenase (LDH) as Prognostic Marker in Acute Leukemia\u201d Quantitative Method\u201d","volume":"8","author":"Walaa Fikry","year":"2017","journal-title":"J. Blood. Disord. Transfus"},{"issue":"5","key":"10.1016\/j.cyto.2024.156721_b0130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tripleo.2009.12.015","article-title":"Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma","volume":"109","author":"Watanabe","year":"2010","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"},{"issue":"11","key":"10.1016\/j.cyto.2024.156721_b0135","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/ijms18112306","article-title":"The CC chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity","volume":"18","author":"Scheu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156721_b0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10555-007-9068-9","article-title":"Chemokines in tumor angiogenesis and metastasis","volume":"26","author":"Singh","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cyto.2024.156721_b0145","series-title":"CCR4 antagonists inhibit Treg trafficking into the tumor microenvironment","first-page":"953","author":"Ketcham","year":"2018"},{"issue":"11","key":"10.1016\/j.cyto.2024.156721_b0150","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.cyto.2024.156721_b0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2298\/SARH0804187S","article-title":"Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia","volume":"136","author":"Stankovi\u0107","year":"2008","journal-title":"Srp. Arh. Celok. Lek."},{"issue":"21","key":"10.1016\/j.cyto.2024.156721_b0160","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cyto.2024.156721_b0165","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/ijc.27966","article-title":"Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4\/CCL22 in head and neck squamous cell carcinoma","volume":"132","author":"Tsujikawa","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cyto.2024.156721_b0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2141.2007.06964.x","article-title":"Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22","volume":"140","author":"Niens","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156721_b0175","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.3324\/haematol.2016.159517","article-title":"Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4\/CXCL12 axis","volume":"102","author":"de Rooij","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cyto.2024.156721_b0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000764","article-title":"Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4","volume":"8","author":"Marshall","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"21","key":"10.1016\/j.cyto.2024.156721_b0185","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.3390\/cancers13215542","article-title":"CCR4 as a therapeutic target for cancer immunotherapy","volume":"13","author":"Yoshie","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cyto.2024.156721_b0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bcmd.2015.07.001","article-title":"Chemokines and relapses in childhood acute lymphoblastic leukemia: a role in migration and in resistance to antileukemic drugs","volume":"55","author":"G\u00f3mez","year":"2015","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.cyto.2024.156721_b0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156721_b0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.cyto.2024.156721_b0205","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4\u2013positive regulatory T cells in Hodgkin lymphoma fosters immune privilege","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.cyto.2024.156721_b0210","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1349-7006.2011.01934.x","article-title":"Aberrant expression of chemokine receptor CCR4 in human gastric cancer contributes to tumor-induced immunosuppression","volume":"102","author":"Yang","year":"2011","journal-title":"Cancer Sci."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:30:54Z","timestamp":1778581854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"alternative-id":["S1043466624002242"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156721","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the CCL17\/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156721"}}